OMERS Administration Corp’s United Therapeutics UTHR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$7.5M	Buy	12,641 +5,764	+84%	+$2.87M	0.05%	174
2025 Q4	$3.35M	Buy	6,877 +1,133	+20%	+$528K	0.02%	253
2025 Q3	$2.41M	Sell	5,744 -4,500	-44%	-$1.51M	0.02%	350
2025 Q2	$2.94M	Buy	10,244 +1,300	+15%	+$389K	0.02%	253
2025 Q1	$2.76M	Buy	8,944 +1,634	+22%	+$560K	0.02%	273
2024 Q4	$2.58M	Sell	7,310 -3,802	-34%	-$1.4M	0.02%	268
2024 Q3	$3.98M	Sell	11,112 -6,800	-38%	-$2.3M	0.04%	198
2024 Q2	$5.71M	Buy	17,912 +15,412	+616%	+$4.08M	0.05%	144
2024 Q1	$574K	Hold	2,500	–	–	0.01%	196
2023 Q4	$550K	Buy	+2,500	New	+$576K	0.01%	172
2019 Q2	–	Sell	-3,200	Closed	-$389K	–	481
2019 Q1	$389K	Buy	+3,200	New	+$373K	﹤0.01%	313
2018 Q4	–	Sell	-19,000	Closed	-$2.43M	–	341
2018 Q3	$2.43M	Buy	+19,000	New	+$2.35M	0.02%	224
2018 Q1	–	Sell	-16,100	Closed	-$2.38M	–	509
2017 Q4	$2.38M	Sell	16,100 -15,800	-50%	-$2.01M	0.02%	231
2017 Q3	$3.74M	Buy	+31,900	New	+$4.07M	0.04%	183
2016 Q4	–	Sell	-21,500	Closed	-$2.54M	–	542
2016 Q3	$2.54M	Buy	+21,500	New	+$2.58M	0.05%	220
2014 Q4	–	Sell	-84,500	Closed	-$10.9M	–	450
2014 Q3	$10.9M	Buy	84,500 +32,800	+63%	+$3.38M	0.32%	73
2014 Q2	$4.58M	Buy	51,700 +2,900	+6%	+$279K	0.15%	104
2014 Q1	$4.59M	Buy	48,800 +12,100	+33%	+$1.24M	0.15%	96
2013 Q4	$4.15M	Buy	+36,700	New	+$3.31M	0.15%	80